A detailed history of Smithbridge Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 44,741 shares of ABBV stock, worth $8.97 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
44,741
Previous 44,458 0.64%
Holding current value
$8.97 Million
Previous $7.63 Million 15.87%
% of portfolio
1.54%
Previous 1.6%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $46,366 - $56,410
283 Added 0.64%
44,741 $8.84 Million
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $406,788 - $475,037
-2,628 Reduced 5.58%
44,458 $7.63 Million
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $221,031 - $251,844
-1,383 Reduced 2.85%
47,086 $8.57 Million
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $86,000 - $96,856
-625 Reduced 1.27%
48,469 $7.51 Million
Q3 2023

Oct 25, 2023

SELL
$133.59 - $154.65 $88,837 - $102,842
-665 Reduced 1.34%
49,094 $7.32 Million
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $24,514 - $30,506
-185 Reduced 0.37%
49,759 $6.7 Million
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $34,850 - $43,368
263 Added 0.53%
49,944 $8.07 Million
Q1 2023

Apr 20, 2023

SELL
$144.61 - $166.54 $38,032 - $43,800
-263 Reduced 0.53%
49,681 $7.92 Million
Q4 2022

Mar 01, 2023

BUY
$138.31 - $165.87 $3.2 Million - $3.84 Million
23,134 Added 86.29%
49,944 $8.07 Million
Q3 2022

Oct 25, 2022

SELL
$134.21 - $153.93 $80,257 - $92,050
-598 Reduced 2.18%
26,810 $3.6 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $68,121 - $86,605
495 Added 1.84%
27,408 $4.2 Million
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $14,253 - $17,685
-108 Reduced 0.4%
26,913 $4.36 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $2.9 Million - $3.67 Million
27,021 New
27,021 $3.66 Million
Q3 2021

Oct 04, 2021

BUY
$106.4 - $120.78 $27,344 - $31,040
257 Added 0.95%
27,178 $2.93 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $49,133 - $54,737
467 Added 1.77%
26,921 $3.03 Million
Q4 2020

Jan 21, 2021

SELL
$80.49 - $108.67 $22,456 - $30,318
-279 Reduced 1.04%
26,454 $2.84 Million
Q2 2020

Jul 01, 2020

SELL
$73.37 - $98.18 $22,011 - $29,454
-300 Reduced 1.11%
26,733 $2.63 Million
Q1 2020

Apr 13, 2020

SELL
$64.5 - $97.79 $103,200 - $156,464
-1,600 Reduced 5.59%
27,033 $2.06 Million
Q4 2019

Jan 09, 2020

SELL
$72.13 - $90.25 $2.04 Million - $2.55 Million
-28,283 Closed
0 $0
Q3 2019

Oct 15, 2019

SELL
$62.98 - $75.72 $31,490 - $37,860
-500 Reduced 1.74%
28,283 $2.14 Million
Q4 2018

Jan 15, 2019

BUY
$77.85 - $96.01 $24,289 - $29,955
312 Added 1.1%
28,783 $2.65 Million
Q3 2018

Oct 05, 2018

SELL
$88.91 - $98.84 $35,119 - $39,041
-395 Reduced 1.37%
28,471 $2.69 Million
Q2 2018

Jul 18, 2018

SELL
$89.78 - $106.23 $128,205 - $151,696
-1,428 Reduced 4.71%
28,866 $2.67 Million
Q1 2018

Apr 09, 2018

BUY
$92.01 - $123.21 $50,237 - $67,272
546 Added 1.84%
30,294 $2.87 Million
Q4 2017

Jan 18, 2018

BUY
$89.56 - $98.21 $20,330 - $22,293
227 Added 0.77%
29,748 $2.88 Million
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $2.06 Million - $2.63 Million
29,521
29,521 $2.62 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Smithbridge Asset Management Inc Portfolio

Follow Smithbridge Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.